Healthcare
Pulmocide secures £17m in series-A
UK-based inhaled medicines developer Pulmocide has raised ТЃ17m in its series-A financing round from a consortium of investors led by Imperial Innovations.
Sofinnova leads €15m round for Pixium
Sofinnova Partners has led a €15m extension of Pixium Vision’s two-part series-A round alongside BPI France and existing investors Omnes Capital and Abingworth Management.
VC-backed Oxford Immunotec raises $64m in IPO
UK-based medical diagnostics company Oxford Immunotec Global, which is backed by a consortium of investors, has listed on the Nasdaq with a market cap of $196.3m.
GE Capital and Ares refinance Astorg's Ethypharm
GE Capital and Ares Management have provided Astorg Partners portfolio company Ethypharm with a €170m unitranche facility.
JLL Partners, Royal DSM create $2.6bn pharma business
US private equity house JLL Partners and Dutch life sciences group Royal DSM have teamed up and combined assets to create a new, independent pharmaceutical company in a deal worth $2.6bn.
Sofinnova Partners et al. sell EOS for up to €310m
Sofinnova Partners, Aescap Venture and Principia have sold Milan-based cancer therapeutics firm Ethical Oncology Science (EOS) to Clovis Oncology via an agreement that could see the firm fetch up to €310m.
Auriga holds €40m first close for Bioseeds fund
French VC Auriga Partners has held a first close on €40m for its latest vehicle, Auriga IV Bioseeds, after seven months on the road.
IBB and HTGF back Scopis in series-A
IBB Beteiligungsgesellschaft and High-Tech Gründerfonds (HTGF) have supported Scopis in a series-A financing round.
Ganymed Pharmaceuticals raises €45m in series-E
Biopharmaceutical company Ganymed Pharmaceuticals has raised €45m in a series-E financing round from MIG and family office ATS Beteiligungsverwaltung.
Mission Therapeutics raises £20m
A syndicate of new and existing venture capital investors has injected ТЃ20m into UK-based biotech Mission Therapeutics as part of its series-B funding round.
Argos Soditic buys Cisbio Bioassays
Argos Soditic has backed the €25m management buyout of French biotech company Cisbio Bioassays.
August buys The Old Deanery Care Village
August Equity has acquired Essex-based care home business The Old Deanery Care Village.
Synoste raises €2.8m in seed round
High-Tech GrУМnderfonds (HTGF), Finnvera, Lifeline Ventures, Tekes and a consortium of business angels have backed medical devices company Synoste with тЌ2.8m.
BPE sells Domilens to Odewald's Polytech
BPE Unternehmensbeteiligungen has sold medical devices manufacturer Domilens to fellow private equity house Odewald & Compagnie’s Polytech Gruppe, a medical equipment supplier.
DFJ Esprit's Oxford Immunotec to float
Oxford Immunotec Global, a UK-based medical diagnostics company, has filed with the US Security and Exchange Commission (SEC) for an IPO on the Nasdaq that would value the company at up to $245.4m.
Italian-German start-up Wise raises €1m
High-Tech Gründerfonds (HTGF), Atlante Seed, b-to-v Partners and Agite have backed medical devices company Wiringless Implantable Stretchable Electronics (Wise) in a €1m seed round.
Vallis joins Inter-Risco in 32 Senses
Vallis Capital Partners has provided expansion capital to Portuguese dental business 32 Senses.
HTGF et al. back HiperScan with €450,000
High-Tech Gründerfonds (HTGF), HCS Beteiligungsgesellschaft and the Technologiegründerfonds Sachsen have backed near-infrared spectroscopy (NIR) developer HiperScan with €450,000.
Sovereign's Eden acquires Essential Futures
UK buy-and-build specialist Sovereign Capital has backed the acquisition of Essential Futures by portfolio company Eden.
PMV backs arGEN-X
PMV has invested €5m in arGEN-X, a Dutch and Belgian biotechnology firm, in an extension of the company’s 2011 series-B round, which now totals €32.5m.
Biocartis secures €30m from PMV et al.
Swiss molecular diagnostics firm Biocartis has raised €30m in its series-E round from a group of investors including PMV, Debiopharm Diagnostics and Johnson & Johnson Development Corporation (JJDC).
Ippon leads £10m investment in Midatech
Nanomedicines manufacturer Midatech has raised ТЃ10m in a funding round led by Geneva-based private equity house Ippon Capital.
Sofinnova, Forbion lead €20m round for Hookipa
A consortium of investors led by Sofinnova Partners and Forbion Capital Partners has invested €20m in a series-B funding round for Austria-based Hookipa Biotech.
EdRip closes fourth life sciences fund on €192m
Edmond de Rothschild Investment Partners (EdRip) has held the final close of its fourth life sciences fund, BioDiscovery 4, on €192m.